Ardonagh Group expands into Australia with acquisition
16-02-2021
04-09-2019
UK insurance intermediary The Ardonagh Group has expanded in Australia with the acquisition of Resilium BidCo, the country s largest independently owned intermediary network.
With offices in Sydney, Melbourne and the Gold Coast, Resilium connects a network of more than 150 Corporate Authorised Representatives (ARs) with over 100 insurers globally, providing business and personal insurance solutions to clients across Australia.
Resilium will continue to be led by managing director Adrian Kitchin, who has overseen the business’ growth trajectory over the past five years, with GWP under management of over A$500 million in 2020, generating revenue of A$19 million for the financial year ending 30 June 2020.
Insurance Age
Subscriptions
Subscriptions
According to Ardonagh, Resilium is the largest independently owned intermediary network in the country.
It has offices in Sydney, Melbourne and the Gold Coast, and connects a network of more than 150 Corporate Authorised Representatives (ARs) with over 100 insurers globally.
Centrepiece
Group CEO David Ross said: “We’re thrilled to be welcoming Resilium into the Ardonagh portfolio as the centrepiece
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact [email protected].
You are currently unable to print this content. Please contact [email protected] to find out more.
A loss in the NSW Supreme Court and action by the Australian Securities and Investments Commission has seen the Australian Financial Complaints Authority forced to change the way it handled complaints relating to authorised representatives.
Register medical devices to place on the market
How to register your medical devices with the Medicines and Healthcare products Regulatory Agency (MHRA) for the markets in Great Britain and Northern Ireland
From: Contents
MHRA under existing arrangements:
MHRA subject to grace periods, depending on the class of devices.
In Great Britain devices must conform to the Medical Devices Regulations 2002 (SI 2002 No 618, as amended) (UK
MDR 2002) as they apply in Great Britain so that they can be registered with the
MHRA.
The
MHRA will only accept registration of devices from manufacturers or UK Responsible Persons that have a place of business in the UK, or from Authorised Representatives based in Northern Ireland (for the purposes of the Northern Ireland market).
Regulating medical devices in the UK
What you need to do to place a medical device on the Great Britain, Northern Ireland and European Union (EU) markets.
From:
MHRA) is responsible for regulating the UK medical devices market.
This guidance provides information on the UK system, including for:
getting your device certified
MHRA
This guidance is divided into sections on the different rules that apply in Great Britain, Northern Ireland and the EU. Great Britain is England, Wales and Scotland.
For Northern Ireland, different rules apply to those in Great Britain. For more information on the regulatory system for medical devices in Northern Ireland, please see Regulation of medical devices in Northern Ireland below.